IS1578B - Aðferðir til að framleiða ný úrefni 2-oxo-1-oxa-8-azaspiro/4,5/decane - Google Patents

Aðferðir til að framleiða ný úrefni 2-oxo-1-oxa-8-azaspiro/4,5/decane

Info

Publication number
IS1578B
IS1578B IS3613A IS3613A IS1578B IS 1578 B IS1578 B IS 1578B IS 3613 A IS3613 A IS 3613A IS 3613 A IS3613 A IS 3613A IS 1578 B IS1578 B IS 1578B
Authority
IS
Iceland
Prior art keywords
ylcarbonyl
alkyl
azaspiro
oxa
oxo
Prior art date
Application number
IS3613A
Other languages
English (en)
Other versions
IS3613A7 (is
Inventor
Toth Edit
Törley Jozsef
Béla Hegedüs DR.
L βszlo Szporny DR.
Kiss Béla
éva P βlosi DR.
Dora Groo Dr.
Istv βn Laszlovszky DR.
Erzsébet Lapis DR.
Auth Ferenc
L βszlo Ga βl DR.
Original Assignee
Richter Gedeon Vegyészeti Gy βr Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyészeti Gy βr Rt. filed Critical Richter Gedeon Vegyészeti Gy βr Rt.
Publication of IS3613A7 publication Critical patent/IS3613A7/is
Publication of IS1578B publication Critical patent/IS1578B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IS3613A 1989-08-10 1990-08-09 Aðferðir til að framleiða ný úrefni 2-oxo-1-oxa-8-azaspiro/4,5/decane IS1578B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894092A HU204054B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same

Publications (2)

Publication Number Publication Date
IS3613A7 IS3613A7 (is) 1991-02-11
IS1578B true IS1578B (is) 1995-06-08

Family

ID=10966859

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3613A IS1578B (is) 1989-08-10 1990-08-09 Aðferðir til að framleiða ný úrefni 2-oxo-1-oxa-8-azaspiro/4,5/decane

Country Status (22)

Country Link
US (1) US5157038A (is)
EP (1) EP0412820B1 (is)
JP (1) JPH0377886A (is)
KR (1) KR940002828B1 (is)
CN (2) CN1029403C (is)
AT (1) ATE102204T1 (is)
AU (1) AU621239B2 (is)
DD (1) DD299430A5 (is)
DE (1) DE69006973T2 (is)
DK (1) DK0412820T3 (is)
ES (1) ES2062386T3 (is)
FI (1) FI903973A7 (is)
HU (1) HU204054B (is)
IE (1) IE62297B1 (is)
IL (1) IL95322A (is)
IS (1) IS1578B (is)
MY (1) MY107125A (is)
NO (1) NO903510L (is)
NZ (1) NZ234844A (is)
PL (2) PL164654B1 (is)
YU (1) YU47749B (is)
ZA (1) ZA906298B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!
KR100863854B1 (ko) * 2004-02-10 2008-10-15 에프. 호프만-라 로슈 아게 케모카인 ｃｃｒ5 수용체 조절제
WO2008092891A1 (en) * 2007-02-01 2008-08-07 Glaxo Group Limited 1-oxa-3-azaspiro(4.5)decan-2-one derivatives for the treatment of eating disorders
WO2008092887A1 (en) * 2007-02-01 2008-08-07 Glaxo Group Limited I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders
JP6503008B2 (ja) * 2017-05-30 2019-04-17 高級アルコール工業株式会社 透明油性固形化粧料

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127065C (is) * 1964-04-22
US3594306A (en) * 1967-04-03 1971-07-20 Great Canadian Oil Sands Separation cell and scavenger cell froths treatment
FR96352E (fr) * 1967-12-29 1972-06-16 Science Union & Cie Nouveaux dérives du spiro (4,5) decane et leur procédé de préparation.
FR2036557A5 (is) * 1969-03-25 1970-12-24 Logeais Laboratoires
GB1301254A (is) * 1971-07-08 1972-12-29
US3856797A (en) * 1972-12-29 1974-12-24 Yoshitomi Pharmaceutical 8-aminoalkyl-3-oxo-1-thia-4,8-diazaspiro(4.5)decanes and analogs thereof
US4244961A (en) * 1978-10-26 1981-01-13 Syntex (U.S.A.) Inc. 1-Oxa-3,8-diazaspiro[4.5]decan-2-ones antihypertensive agents
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL95322A (en) 1994-01-25
IE902883A1 (en) 1991-02-27
PL286441A1 (en) 1991-07-15
IE62297B1 (en) 1995-01-25
DK0412820T3 (da) 1994-03-28
ATE102204T1 (de) 1994-03-15
FI903973A0 (fi) 1990-08-10
CN1049348A (zh) 1991-02-20
CN1049347A (zh) 1991-02-20
KR940002828B1 (ko) 1994-04-04
AU6080590A (en) 1991-02-14
US5157038A (en) 1992-10-20
NO903510D0 (no) 1990-08-09
NZ234844A (en) 1992-03-26
ES2062386T3 (es) 1994-12-16
CN1029403C (zh) 1995-08-02
PL164654B1 (pl) 1994-08-31
PL164653B1 (en) 1994-08-31
IL95322A0 (en) 1991-06-30
HU204054B (en) 1991-11-28
DE69006973T2 (de) 1994-06-16
YU47749B (sh) 1996-01-08
CN1028531C (zh) 1995-05-24
DE69006973D1 (de) 1994-04-07
YU153990A (sh) 1992-12-21
EP0412820B1 (en) 1994-03-02
DD299430A5 (de) 1992-04-16
KR910004629A (ko) 1991-03-29
JPH0377886A (ja) 1991-04-03
EP0412820A2 (en) 1991-02-13
IS3613A7 (is) 1991-02-11
EP0412820A3 (en) 1991-11-27
FI903973A7 (fi) 1991-02-11
MY107125A (en) 1995-09-30
AU621239B2 (en) 1992-03-05
NO903510L (no) 1991-02-11
ZA906298B (en) 1991-06-26
HUT55783A (en) 1991-06-28

Similar Documents

Publication Publication Date Title
ATE205206T1 (de) Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
FI942499A0 (fi) Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
MY107240A (en) Novel 2-oxo-3, 8-diazaspiro [4,5] decane derivatives, pharmaceuticals compositions containing them and process for preparing same.
DK0414422T3 (da) 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf
IS3613A7 (is) Aðferðir til að framleiða ný úrefni 2-oxo-1-oxa-8-azaspiro/4,5/decane
HUT51597A (en) Process for production of derivatives of n,n-disubstituated diaryl-alcane-carbonic acid amid and medical compositions containing them as active substances
ATE103920T1 (de) 1-oxa-2-oxo-8-azaspiro(4,5>decan-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen daraus.
NO862054L (no) Fremgangsmaate for fremstilling av nye berbanderivater.
ATE79259T1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
HUT69166A (en) Process to preparare pharmaceutical compns. to prevent and to cure ulcus